About this document

Vonoprazan: Breakthrough in Acid Disease Treatment by Mohit Tripathi is a document available to read on EtoBox.

Vonoprazan is a potassium-competitive acid blocker (P-CAB) that offers a significant advancement in the treatment of acid-related diseases, addressing the limitations of traditional proton pump inhibitors (PPIs). It provides rapid and sustained acid suppression, is not affected by CYP2C19 polymorphisms, and has demonstrated superior efficacy in various clinical applications, including healing erosive esophagitis and treating H. pylori infections. With its USFDA approval, Vonoprazan represents a paradigm shi

Author

Mohit Tripathi

Language

EN